Study of in vivo and in vitro resting vasodilator nitric oxide tone in normotensive and genetically hypertensive rats

European Journal of Pharmacology

Volumn 310, Issue 2-3, 1996, Pages 175-183

  Gil Longo, José ^a   Fdez Grandal, Dolores ^a   Álvarez, Marta ^a   Sieira, Manuela ^a   Orallo, Francisco ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Aorta, rat; Arterial pressure; Endothelium; Hypertension; Methylene blue; N(G) Nitro L arginine; Nitric oxide (NO)

Indexed keywords

HEXAMETHONIUM; INDOMETACIN; METHYLENE BLUE; N(G) NITROARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEREDITARY HYPERTENSION; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

EID: 0030605983     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00392-5     Document Type: Article

References (38)

1. +]: a functional approach to separating EDHF-related and EDNO-related mechanisms in perfused rat mesenteric arterial bed, J. Cardiovasc. Pharmacol. 21, 423.
2. G-nitro-L-arginine methyl ester on cirazoline-and KCl-induced responses in the perfused mesenteric arterial bed of rats, Br. J. Pharmacol. 111, 13.
3. Charpie, J.R. and R.C. Webb, 1993, Vascular myocyte-derived nitric oxide is an autocrine that limits vasoconstriction, Biochem. Biophys. Res. Commun. 194, 763.
4. Clozel, M., 1991, Mechanism of action of angiotensin converting enzyme inhibitors on endothelial function in hypertension, Hypertension 18, 11-37.
5. Colden-Stanfield, M., W.P. Schilling, A.K. Ritchie, S.G. Eskin, L.T. Navarro and D.L. Kunze, 1987, Bradykinin-induced increases in cytosolic calcium and ionic currents in cultures bovine aortic endothelial cells, Circ. Res. 61, 632.
6. +-contracted rabbit and rat aortae, J. Physiol. (London) 400, 395.
7. Dohi, Y., M.A. Thiel, F.R. Buhler and T.F. Lüscher, 1990, Activation of endothelial L-arginine pathway in resistance arteries, Effect of age and hypertension, Hypertension 15, 170.
8. Folkow, B., 1990, 'Structural factor' in primary and secondary hypertension, Hypertension 16, 89.
9. Förstermann. U., E.I. Closs, J.S. Pollock, M. Nakane, P. Schwarz, I. Gath and H. Kleinert, 1994, Nitric oxide synthase isozymes - characterization, purification, molecular cloning, and functions, Hypertension 23, 1121.
10. G-monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyoto rats, Br. J. Pharmacol. 102, 823.
11. Hofman, W.F., H.A. El-Kashef, J. Endrédi and LC. Ehrhart, 1992, Effect of methylene blue on vasoreactivity in dog lung, Am. J. Physiol. 263, H587.
12. ω-Nitro-L-arginine: a potent inhibitor of endothelium-drived relaxing factor formation, Eur. J. Pharmacol. 176, 216.
13. Kobayashi, Y., K. Ikeda, E. Shinozuka, Y. Nara, Y, Yamori and K. Hattori, 1991, Comparison of vasopressor effects of nitro arginine in stroke-prone spontaneously hypertensive rats and Wistar-Kyoto rats, Clin. Exp. Pharmacol. Physiol. 18, 599.
14. Koller, A. and A. Huang, 1994, Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats, Circ. Res. 74, 416.
15. G-Nitro arginine produces an exaggerated hypertension in anesthetized SHR, Eur. J. Pharmacol. 197, 239.
16. Lacolley, P.J., S.J. Lewis and M.J. Brody, 1991b, Role of sympathetic nerve activity in the generation of vascular nitric oxide in urethane-anesthetized rats, Hypertension 17, 881.
17. Li, F. and I.G. Joshua, 1993, Decreased arteriolar endothelium-derived relaxing factor production during the development of genetic hypertension, Clin. Exp. Hyperten. 15, 511.
18. Lüscher, T.F., 1993, The endothelium as a target and mediator of cardiovascular disease, Eur. J. Clin. Invest. 23, 670.
19. Marczin, N., U.S. Ryan and J.D. Catravas, 1992. Methylene blue inhibits nitrovasodilator-and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J. Pharmacol. Exp. Ther. 263, 170.
20. Martin, W., K. Drazan and A.C. Newby. 1989, Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells, Br. J. Pharmacol. 97, 51.
21. Martin, W., G.M. Villani, D. Jothianandan and R.F. Furchgott, 1985, Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta, J. Pharmacol. Exp. Ther. 232, 708.
22. Mayer, B., F. Brunner and K. Schmidt, 1993a, Inhibition of nitric oxide synthesis by methylene blue, Biochem. Pharmacol. 45, 367.
23. Mayer, B., M. Schmid, P. Klatt and K. Schmidt, 1993b, Reversible inactivation of endothelial nitric oxide synthase by N(G)-nitro-L-arginine, FEBS Lett. 333, 203.
24. Moncada, S., R.M.J. Palmer and E.A. Higgs, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 43, 109.
25. Mourlon-Le Grand, M.C., J. Benessiano and B.I. Levy, 1993, Endothelium, mechanical compliance, and cGMP content in the carotid artery from spontaneously hypertensive rats, J. Cardiovasc. Pharmacol. 21 (Suppl. 1). S26.
26. Panza, J.A., P.R. Casino, C.M. Kilcoyne and A.A. Quyyumi, 1993, Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension, Circulation 87, 1468.
27. Peterson, D.A., D.C. Peterson, S. Archer and E.K. Weir, 1992, The non specificity of specific nitric oxide synthase inhibitors, Biochem. Biophys. Res. Commun. 187, 797.
28. Pourageaud, F. and J.L. Freslon, 1992, Endothelium function in resistance and coronary arteries of spontaneously hypertensive compared to WKY rats: effects of nitro-L-arginine, Gen. Hypertens. 218, 39.
29. Randall, M.D., G.R. Thomas and C.R. Hiley, 1991, Effect of destruction of the vascular endothelium upon pressure/flow relations and endothehum-dependent vasodilatation in resistance beds of spontaneously hypertensive rats, Clin. Sci. 80, 463.
30. Rees, D.D., R.M. Palmer. R. Schulz, H.F. Hodson and S. Moncada, 1990, Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo, Br. J. Pharmacol. 101, 746.
31. Ruiz, F.J., A.C. Ingles, T. Quesada, M.G. Salom and L.F. Carbonell, 1994, Indomethacin does not modify the role of nitric oxide on blood pressure regulation of SHR, Gen. Pharmacol. 25, 103.
32. ω-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, bradykinin, and substance P, Eur. J. Pharmacol. 254, 207.
33. G-nitro-L-arginine methyl ester, Hypertension 9, S192.
34. Vane, J.R., E.E. Anggard and R.M. Bottine, 1990, Regulatory functions of the vascular endothelium, New Engl. J. Med. 323, 27.
35. Vargas, H.M., L.I. Ignarro, G. Chaudhuri and G. Chaudhuri, 1990, Physiological release of nitric oxide is dependent on the level of vascular tone, Eur. J. Pharmacol. 190, 393.
36. G-nitro-L-arginine contracts vascular smooth muscle by an endothelium-independent mechanism, J. Cardiovasc. Pharmacol. 24, 59.
37. Wood, K.S., G.M. Buga, R.E. Byrns and L.J. Ignarro, 1990, Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide, Biochem. Biophys. Res. Commun. 170, 80.
38. Xiao, J. and P.K.T. Pang, 1994, Does a general alteration in nitric oxide synthesis system occur in spontaneously hypertensive rats?, Am. J. Physiol. 266, H272.